← brief for 2026-10-08 · Slowing decline
New potassium binders: we need them - we do not need them
Key takeaways
This is a debate article about new drugs that lower potassium levels. It discusses whether these new drugs are better than older, cheaper options. It does not report new trial results. It is an opinion piece weighing clinical utility and cost.
Who did this work
Luca De Nicola · Marie Evans (Karolinska University Hospital) · Juergen Floege (Universitätsklinikum Aachen) · Carmine Zoccali (Biogem)
Source
Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-07
https://doi.org/10.1093/ckj/sfag360